Inference Under Covariate‐Adaptive Randomization Using Random Center‐Effect

The minimization method is a popular choice for covariate-adaptive randomization in multicenter trials. Existing literature suggests that the type-I error is controlled if minimization variables are included in the statistical analysis. However, in practice, minimization variables with many categories, such as the recruitment center, are often not included in the model. In this paper, we propose including the minimization variable "center" as a random effect and assess its performance using simulations for Gaussian, binary, and Poisson endpoint variables. Our simulation study suggests that the random-effect model controls type-I error and preserves maximum power for all three endpoints under varied clinical trial settings. This approach offers an alternative to the re-randomization test, which regulatory authorities often suggest for sensitivity analysis.

Authors

Institutions

Publication Details

Journal
Biometrical Journal
Published
2025-09-22
DOI
https://doi.org/10.1002/bimj.70076
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inference Under Covariate‐Adaptive Randomization Using Random Center‐Effect

Anjali Pandey, Andrea Callegaro, Harsha Shree BS
Biometrical Journal
Statistical Methods in Clinical Trials
article

Inference Under Covariate‐Adaptive Randomization Using Random Center‐Effect

Anjali Pandey, Andrea Callegaro, Harsha Shree BS
article en

Abstract

The minimization method is a popular choice for covariate-adaptive randomization in multicenter trials. Existing literature suggests that the type-I error is controlled if minimization variables are included in the statistical analysis. However, in practice, minimization variables with many categories, such as the recruitment center, are often not included in the model. In this paper, we propose including the minimization variable "center" as a random effect and assess its performance using simulations for Gaussian, binary, and Poisson endpoint variables. Our simulation study suggests that the random-effect model controls type-I error and preserves maximum power for all three endpoints under varied clinical trial settings. This approach offers an alternative to the re-randomization test, which regulatory authorities often suggest for sensitivity analysis.

Biometrical JournalVol. 67(5)
Infosys (India) (IN), GlaxoSmithKline (Switzerland) (CH), Indian Statistical Institute (IN)
Openalex Percentile: Top 76%
Statistical Methods in Clinical Trials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.